NASDAQ: CAI
Caris Life Sciences Inc Stock Ownership - Who owns Caris Life Sciences?

Insider buying vs selling

Have Caris Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan Kenneth Charles KnowlesDirector2026-05-291,600$15.62
$24.99kBuy
George PosteDirector2026-05-291,600$15.62
$24.99kBuy
David Baxley SpetzlerPresident2026-05-1513,856$15.25
$211.30kSell
Luke Thomas PowerSenior Vice President Chief Financial Officer and Chief Accounting Officer2026-05-159,771$15.25
$149.01kSell
John Russel DentonSenior Vice President General Counsel and Secretary2026-05-156,047$15.25
$92.22kSell
Jon HalbertDirector2026-05-1568,000$14.56
$990.08kBuy
David D. HalbertFounder Chairman and Chief Executive Officer2026-05-1540,712$15.25
$620.86kSell
Brian J. BrilleVice Chairman and Executive Vice President2026-05-1513,987$15.25
$213.30kSell
Jeff L. VacircaDirector2026-05-1131,050$16.15
$501.43kBuy
David Paul FredricksonDirector2026-02-262,492$20.06
$49.99kBuy

1 of 3

CAI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAI insiders and whales buy or sell their stock.

CAI Shareholders

What type of owners hold Caris Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David D. Halbert49.48%139,863,002$2.28BInsider
Fmr LLC10.89%30,785,585$502.42MInstitution
Tssp Subfund Holdco LLC8.63%24,385,399$397.97MInsider
J H Whitney VI L P7.17%20,256,615$330.59MInsider
J H Whitney Equity Partners VI LLC6.46%18,256,615$297.95MInstitution
Adapt I Ltd5.99%16,943,232$276.51MInsider
Sixth Street Partners Management Company LP5.09%14,385,399$234.77MInstitution
Peter M. Castleman3.68%10,395,044$169.65MInsider
Coatue Management LLC3.47%9,819,992$160.26MInstitution
Braidwell LP2.83%8,009,447$130.71MInstitution

1 of 3

CAI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAI41.84%58.16%Net SellingNet Buying
CELC84.54%15.46%Net SellingNet Selling
DFTX63.13%36.87%Net SellingNet Selling
MANE62.15%15.06%Net Buying
ACAD71.81%28.19%Net SellingNet Selling

Caris Life Sciences Stock Ownership FAQ

Who owns Caris Life Sciences?

Caris Life Sciences (NASDAQ: CAI) is owned by 55.49% institutional shareholders, 77.14% Caris Life Sciences insiders, and 0.00% retail investors. David D. Halbert is the largest individual Caris Life Sciences shareholder, owning 139.86M shares representing 49.48% of the company. David D. Halbert's Caris Life Sciences shares are currently valued at $2.25B.

If you're new to stock investing, here's how to buy Caris Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.